UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

______________________

FORM 8-K

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

October 2, 2014

Date of Report (Date of earliest event reported)

BOVIE MEDICAL CORPORATION

(Exact name of registrant as specified in its Charter)

Delaware	012183	11-2644611
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

5115 Ulmerton Rd., Clearwater, Florida 33760

(Address of principal executive offices) (Zip Code)

(800) 537-2790

Registrant's telephone number, including area code

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01                      Other Events

On October 2, 2014, the United States District Court for the Middle District of Florida, Tampa Division (the “Court”), entered an order and final judgment approving the previously announced settlement of the stockholder derivative action entitled Arbit, et al v. Makrides, et al (the “Stockholder Derivative Action”). The Stipulation of Settlement evidencing the settlement of the Stockholder Derivative Action was entered into on June 26, 2014 and was filed as Exhibit 99.1 to the Company’s Current Report on Form 8-K filed on July 2, 2014.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: October 3, 2014	BOVIE MEDICAL CORPORATION
	By:    /s/ Robert L. Gershon
	Robert L. Gershon
	Chief Executive Officer

2